Irvine, CA, United States of America

Brian Cummings

This inventor holds 6 USPTO granted patents and 2 published patent applications. Top assignees: University of Georgia Research Foundation Inc, Other. Active years: 1998-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Brian Cummings. Retrieved from https://idiyas.com/inventor/brian-cummings-uxdjlbyx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 100.0

Average Co-Inventor Count = 2.5

ph-index = 3

Forward Citations = 42(Granted Patents)


Location History:

  • Lincoln, MA (US) (1998)
  • Irvine, CA (US) (2006 - 2014)
  • Athens, GA (US) (2022 - 2024)

Company Filing History:

goldMedal2 out of 871 
 
University of Georgia Research Foundation Inc
 patents
silverMedal3 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 1998-2024

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Brian Cummings: Innovator in Lipid-Based Delivery Systems

Introduction

Brian Cummings is a notable inventor based in Irvine, CA (US), recognized for his contributions to the field of lipid-based delivery systems. With a total of 6 patents, he has made significant strides in developing innovative compositions for medical applications, particularly in cancer treatment.

Latest Patents

Cummings' latest patents focus on IPA-3-loaded liposomes and methods of use thereof. These lipid-based delivery vehicles are designed to enhance the delivery of nanoparticulate compositions that include a p21 activated kinase (PAK) inhibitor. The preferred embodiment of this delivery vehicle is a sterically-stabilized liposome, which typically comprises one or more phospholipids and optionally a sterol. In specific formulations, the lipid-based delivery vehicle includes DSPC, DSPE-PEG2000, and cholesterol in a ratio of 9:1:5. The nanoparticulate composition is particularly aimed at delivering a PAK-1 inhibitor, such as IPA-3, for methods of treating cancers, including prostate and breast cancer.

Career Highlights

Throughout his career, Brian Cummings has worked with various organizations, including the University of Georgia Research Foundation, Inc. His work has been pivotal in advancing the understanding and application of lipid-based delivery systems in therapeutic contexts.

Collaborations

Cummings has collaborated with notable individuals in his field, including Carl W Cotman and Charles F Chubb. These collaborations have contributed to the development of innovative solutions in the realm of nanoparticulate compositions.

Conclusion

Brian Cummings stands out as an influential inventor in the field of lipid-based delivery systems, with a focus on improving cancer treatment methodologies. His innovative patents and collaborations reflect his commitment to advancing medical science through effective delivery mechanisms.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…